Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Decrease of contact allergy to hydroxyisohexyl 3-cyclohexene carboxaldehyde in Europe prior to its ban and diagnostic value

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Incidence rates of occupational contact dermatitis in Denmark between 2007 and 2018 - A population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aluminium contact allergy without vaccination granulomas: A systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Nickel release from metallic earrings: A survey of the Danish market and validation of the nickel spot test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Memory T helper cells identify patients with nickel, cobalt, and chromium metal allergy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Incidence rates of occupational contact dermatitis in Denmark between 2007 and 2018 - A population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aluminium contact allergy without vaccination granulomas: A systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Nickel release from metallic earrings: A survey of the Danish market and validation of the nickel spot test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Memory T helper cells identify patients with nickel, cobalt, and chromium metal allergy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) has been the most reported fragrance chemical for two decades and will be prohibited in cosmetic products from August 2021.

OBJECTIVES: To describe the time trend of HICC contact allergy in European patients with dermatitis in 2009 to 2019, and the added value of testing HICC separately in the baseline series.

METHODS: Data were reviewed for 124 472 patients with dermatitis who were patch tested with HICC 5% pet. in the baseline series in the European Surveillance System on Contact Allergy (ESSCA) network (2009 to 2018) and at the Herlev-Gentofte Hospital Department of Dermatology and Allergy (2009 to 2019).

RESULTS: Contact allergy to HICC was found in 1.98% of 9865 patients in Gentofte and 1.62% of 114 607 patients in the ESSCA network. Overall, the prevalence decreased annually, with 0.156 percentage points (P = .001) in Gentofte and 0.051 percentage points (P = .0002) in ESSCA. The frequency of missed contact allergy to HICC when testing only with fragrance mix II (FMII) was 0.17% (17/9865) and 0.35% (405/114607) of the whole test population in the Gentofte and ESSCA populations, respectively.

CONCLUSIONS: This is the first study to demonstrate a significant decline in HICC allergy in European patients with dermatitis, most likely attributed to the upcoming European ban.

OriginalsprogEngelsk
TidsskriftContact Dermatitis
Vol/bind84
Udgave nummer6
Sider (fra-til)419-422
Antal sider4
ISSN0105-1873
DOI
StatusUdgivet - jun. 2021

ID: 65571624